A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study

A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study

Sverre Lehmann,1,2 Thomas Ringbæk,3 Anders Løkke,4 Ludger Grote,5 Jan Hedner,6 Eva Lindberg7 1Department of Thoracic Medicine, Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital, Bergen, Norway; 2Section of Thoracic Medicine, Department of Clinical Sc...

Full description

Bibliographic Details
Main Authors: Lehmann S, Ringbæk T, Løkke A, Grote L, Hedner J, Lindberg E
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:International Journal of COPD
Subjects:
Bronchodilator
sleep
hypoxia
quality of life
lung function
Online Access:https://www.dovepress.com/a-randomized-trial-to-determine-the-impact-of-indacaterolglycopyrroniu-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/a-randomized-trial-to-determine-the-impact-of-indacaterolglycopyrroniu-peer-reviewed-article-COPD

Similar Items